Men Treated for Localized Prostate Cancer Could Benefit from Pomegranate Juice Consumption

	Tweet

Pomegranate juice may slow the progression of post-treatment prostate cancer recurrence, according to new long-term research results being presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA). Researchers found that men who have undergone treatment for localized prostate cancer could benefit from drinking pomegranate juice.

The two-stage clinical trial followed a total of 48 participants over six years. Eligible participants had a rising PSA after surgery or radiotherapy, a PSA greater than 0.2 ng/ml and less than 5 ng/ml and a Gleason score of 7 or less. These patients were treated by drinking eight ounces of pomegranate juice daily. Currently, in the sixth year of treatment, active patients who remain on the study have a median total follow-up of 56 months. These participants continue to experience a significant increase in PSA doubling time following treatment, from a mean of 15.4 months at baseline to 60 months post-treatment, with a median PSA slope decrease of 60 percent, 0.06 to 0.024.

Researchers compared active patients, who remain on the study, with non-active patients, who no longer remain on the study. Though these two groups demonstrated similar mean PSA doubling times at baseline, both the PSA doubling time prolongation and the decline in median PSA slope were greater in active patients when compared to non-active patients.

“This study suggests that pomegranate juice may effectively slow the progression of prostate cancer after unsuccessful treatment,” said Christopher Amling, MD, an AUA spokesman. “This finding and other ongoing research might one day reveal that pomegranate juice is an effective prostate cancer preventative agent as well.”

Parts of this ongoing study suggest that some patients may be more sensitive to the effects of pomegranate juice on PSA doubling time. Phase three of this study is currently underway to further evaluate the benefits of pomegranate juice in a placebo-controlled manner.

NOTE TO REPORTERS: Experts are available to discuss these studies outside normal briefing times.

Pantuck, A; Zomorodian, N; Rettig, M; Aronson, W; Heber, D; Belldegrun, A. Long term follow up of phase 2 study of pomegranate juice for men with prostate cancer shows durable prolongation of PSA doubling time. J Urol, suppl. 2009: 181, 4, abstract 826.

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is the pre-eminent professional organization for urologists, with more than 16,000 members throughout the world. An educational nonprofit organization, the AUA pursues its mission of fostering the highest standards of urologic care by carrying out a wide variety of programs for members and their patients.

Source: American Urological Association (AUA)

RELATED STORIES:
How Advanced Prostate Cancer Becomes Resistant to Androgen-deprivation Therapy   Urine test may detect aggressive prostate tumors   Baldness drug could mask prostate cancer marker   Prostate cancer clinical stage does not predict recurrence   Possible link found between x-rays and prostate cancer   Younger men with advanced prostate cancer have shorter survival times   Model of Prostate Cancer Helps Identify Promising Pain Treatment   A new ground zero for prostate cancer   Profiling prostate cancer   Low-grade prostate cancer may not require aggressive treatment   Should the UK lower the age for prostate cancer detection?   Prostate cancer spurs new nerves   Few Side Effects from Radiation Treatment Given After Prostate Cancer Surgery   New drug targets vitamin D receptors in hormone resistant prostate cancers   Shorter radiation course stops cancer growth in high-risk prostate cancer patients   Prostate cancer screening may not reduce mortality   Trapping prostate cancer cells to keep them from spreading provides hope   Common painkillers lower levels of prostate cancer biomarker   Botox relieves BPH symptoms   Screening for Prostate Cancer May Not Reduce Men’s Risk of Death   Older men may not need prostate cancer screening   Gene Markers Located for Hereditary Prostate Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]